Navigation Links
Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event
Date:1/12/2011

PARSIPPANY, N.J., Jan. 12, 2011 /PRNewswire/ -- In 2011, what will be the major trends in the pharmaceutical industry?  What will drive innovation?  How will government regulations affect what's next and what's new?  What will the game changers be?  Who will survive in the competitive corporate landscape?  When it comes to market research, what's the smartest and most effective way to get the job done right? The answers to these questions and much more will be revealed at a pivotal, groundbreaking event - the Pharma Market Research Conference on February 1-2, in Parsippany, New Jersey.

The Pharma Market Research Conference is your EXCLUSIVE ENTRY into the world of pharmaceutical market research.  This is the most important and impactful event in pharmaceutical market research.  Nowhere else will you find the industry's best and brightest all under one roof!  

Located in the heart of New Jersey's Pharmaceutical Corridor, this event is an essential destination that shines a spotlight on the pharma industry for the world's most noteworthy market research executives.

The Pharma Market Research Conference's impressive advisory board includes senior-level thought leaders from Bayer, Eisai, Johnson & Johnson, Lundbeck, Merck, Pfizer, Purdue, Shire, and Takeda.  With their executive leadership, the Pharma Market Research Conference offers an intensive agenda for anyone wanting to network with and learn from the industry's best.

Talented speakers come from world class companies, including Abbott, Acorda Therapeutics, Alkermes, Allergan, AstraZeneca, Covidien, Daiichi Sankyo, Eisai, Johnson & Johnson, Lundbeck, Merck, Novartis, Pfizer, Roche, Shire, Takeda, ViroPharma & more!  For more about the speakers, go to: http://pharmamarketresearchconference.com/speakers

See what exciting innovations and solutions are being offered by 2011's premier sponsors/exhibitors, which include Ipsos Health, Segmedica, Affinnova, A+A Research, BioMedTracker, CBR Pharma Insights, ClarityQMR, Docnography, Dolcera, Drug Development Insights, Epocrates, Financial Times, Healogix, HRA Research, Life Science Analytics, ListenLogic, M3 Global Research, Medefield, MedPredict, Murray Hill Center, National Analysts Worldwide, Northern Light, Optimal Strategix, Reckner, The Research Partnership, Survey Sampling, Toluna, Truth On Call, Verilogue, and WorldOne.

The Pharma Market Research Conference only happens once a year.  More than 200 people came last time; 2011 is expected to be even bigger and better.  For more information or to register, call +1.212.228.7974 or go to: http://pharmamarketresearchconference.com/


'/>"/>
SOURCE Pharma Market Research Conference
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... TREE, Colo. , March 29, 2017  Zynex (OTCQB: ... manufacture and sale of non-invasive medical devices for pain ... today that it will host the Company,s 2016 full-year ... a.m. Eastern Time.) The Company expects to ... 31, 2017. ...
(Date:3/29/2017)... , March 29, 2017 According to a new ... Type (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, ... 2021" published by MarketsandMarkets, the market is expected to reach USD 1,215.4 ... of 6.5% from 2016 to 2021. Continue ... ...
(Date:3/29/2017)... , March 29, 2017  The Pharmaceutical Care ... a new PhRMA report on patient out-of-pocket spending: ... Medicare and Medicaid Services (CMS), the average amount spent ... 13% of drug spending in 2016, down from 23% ... a pricing problem, not a coverage problem. Health plans ...
Breaking Medicine Technology:
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... and women’s professional squash, announced it has enlisted New York City-based sports and ... agency will develop and procure sponsorship opportunities for the Professional Squash Association (PSA), ...
(Date:3/29/2017)... ... 30, 2017 , ... Youth Futures International (YFI) premiered its Serve, Learn, & ... and college students who have participated in the program every summer. The 2017 ... accepting applications for enrollment. Visit http://www.ghana.yfiexperience.org to learn more. , “I ...
(Date:3/29/2017)... ... 29, 2017 , ... AngioGenesis Labs sold 300 bottles of ... Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while doing a ... over the counter heart healthy drink, can reduce Arterial Plaque, Lower Blood Pressure, ...
(Date:3/29/2017)... ... , ... Dr. Angela Cotey, a noted general dentist in Mt. Horeb, is ... or without a referral. Dr. Cotey knows that interceptive orthodontics in Mt. ... patients receive early treatment, they may achieve straight teeth with less treatment in their ...
(Date:3/29/2017)... ... 2017 , ... Curio Wellness , a premium medical cannabis brand and ... executive management team with prominent executives from both inside and outside the cannabis industry. ... Ted Dumbauld , who has more than twenty years of business leadership and ...
Breaking Medicine News(10 mins):